[Clinical use of phosphodiesterase-5 inhibitors in cardiopulmonary diseases: from experimental evidence to clinical application].

PubWeight™: 0.79‹?›

🔗 View Article (PMID 20101899)

Published in G Ital Cardiol (Rome) on January 27, 2010

Authors

Marco Guazzi1, Marco Vicenzi, Michele Samaja

Author Affiliations

1: Unità Cardiopolmonare, Ospedale San Paolo, Università degli Studi, Milano. marco.guazzi@unimi.it

Articles citing this

Pulmonary hypertension in patients with hematological disorders following splenectomy. Indian J Hematol Blood Transfus (2010) 0.76

Articles by these authors

Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation (2011) 5.06

PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study. Circ Heart Fail (2010) 2.82

Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol (2007) 2.51

Chronic hypoxia: a model for cyanotic congenital heart defects. J Thorac Cardiovasc Surg (2002) 2.11

Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights. Circ Heart Fail (2009) 1.25

The minute ventilation/carbon dioxide production slope is prognostically superior to the oxygen uptake efficiency slope. J Card Fail (2007) 1.12

A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo. Am J Physiol Heart Circ Physiol (2006) 1.08

Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation rates. Biochem J (2006) 1.07

Hypoxia: unique myocardial morphology? J Thorac Cardiovasc Surg (2004) 1.03

Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study. Eur J Heart Fail (2011) 1.02

Partial persistence of exercise-induced myocardial angiogenesis following 4-week detraining in the rat. Histochem Cell Biol (2008) 1.01

Mild exercise training, cardioprotection and stress genes profile. Eur J Appl Physiol (2007) 0.98

Chronic and intermittent hypoxia induce different degrees of myocardial tolerance to hypoxia-induced dysfunction. Exp Biol Med (Maywood) (2002) 0.97

Kinetics of NO and O2 binding to a maleimide poly(ethylene glycol)-conjugated human haemoglobin. Biochem J (2004) 0.97

Acid-base balance at exercise in normoxia and in chronic hypoxia. Revisiting the "lactate paradox". Eur J Appl Physiol (2003) 0.96

Exercise oscillatory ventilation may predict sudden cardiac death in heart failure patients. J Am Coll Cardiol (2007) 0.95

The role of PDE5-inhibitors in cardiopulmonary disorders: from basic evidence to clinical development. Curr Med Chem (2007) 0.94

Effect of contraction frequency on the contractile and noncontractile phases of muscle venous blood flow. J Appl Physiol (1985) (2003) 0.94

Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia. Proc Natl Acad Sci U S A (2006) 0.92

Cellular distribution of Hsp70 expression in rat skeletal muscles. Effects of moderate exercise training and chronic hypoxia. Cell Stress Chaperones (2008) 0.90

Amino acid- and lipid-induced insulin resistance in rat heart: molecular mechanisms. Mol Cell Endocrinol (2002) 0.90

Phosphodiesterase-5 inhibition abolishes neuron apoptosis induced by chronic hypoxia independently of hypoxia-inducible factor-1alpha signaling. Exp Biol Med (Maywood) (2008) 0.89

Chronic in vivo hypoxia in various organs: hypoxia-inducible factor-1alpha and apoptosis. Biochem Biophys Res Commun (2006) 0.89

Simultaneous determination of purine nucleotides, their metabolites and beta-nicotinamide adenine dinucleotide in cerebellar granule cells by ion-pair high performance liquid chromatography. Brain Res Brain Res Protoc (2003) 0.89

Impact of the phosphatidylinositide 3-kinase signaling pathway on the cardioprotection induced by intermittent hypoxia. PLoS One (2013) 0.89

Gene expression profile of rat left ventricles reveals persisting changes following chronic mild exercise protocol: implications for cardioprotection. BMC Genomics (2009) 0.89

Phosphorylation of phosphatidylinositol-3-kinase-protein kinase B and extracellular signal-regulated kinases 1/2 mediate reoxygenation-induced cardioprotection during hypoxia. Exp Biol Med (Maywood) (2010) 0.89

Phosphodiesterase-5 inhibition mimics intermittent reoxygenation and improves cardioprotection in the hypoxic myocardium. PLoS One (2011) 0.88

Apelin-13 limits infarct size and improves cardiac postischemic mechanical recovery only if given after ischemia. Am J Physiol Heart Circ Physiol (2011) 0.86

Heart HIF-1alpha and MAP kinases during hypoxia: are they associated in vivo? Exp Biol Med (Maywood) (2007) 0.85

Myocardial tolerance to ischemia-reperfusion injury, training intensity and cessation. Eur J Appl Physiol (2010) 0.84

Antitumour activity of melatonin in a mouse model of human prostate cancer: relationship with hypoxia signalling. J Pineal Res (2014) 0.84

Myocardial impairment in chronic hypoxia is abolished by short aeration episodes: involvement of K+ATP channels. Exp Biol Med (Maywood) (2004) 0.84

Daily reoxygenation decreases myocardial injury and improves post-ischaemic recovery after chronic hypoxia. Eur J Cardiothorac Surg (2009) 0.83

Brief reoxygenation episodes during chronic hypoxia enhance posthypoxic recovery of LV function: role of mitogen-activated protein kinase signaling pathways. Basic Res Cardiol (2006) 0.83

In vivo up-regulation of the unfolded protein response after hypoxia. Biochim Biophys Acta (2012) 0.82

Xanthine oxido-reductase activity in ischemic human and rat intestine. Free Radic Res (2004) 0.82

Effect of enalapril on exercise cardiopulmonary performance in chronic obstructive pulmonary disease: A pilot study. Pulm Pharmacol Ther (2010) 0.82

Development of a cardiopulmonary exercise prognostic score for optimizing risk stratification in heart failure: the (P)e(R)i(O)dic (B)reathing during (E)xercise (PROBE) study. J Card Fail (2010) 0.81

Cytochrome c oxidase expression in chronic and intermittent hypoxia rat gastrocnemius muscle quantitated by CE. Electrophoresis (2006) 0.81

Protein modulation in mouse heart under acute and chronic hypoxia. Proteomics (2011) 0.81

Cardiopulmonary exercise testing characteristics in heart failure patients with and without concomitant chronic obstructive pulmonary disease. Am Heart J (2010) 0.80

F0F1 ATP synthase activity is differently modulated by coronary reactive hyperemia before and after ischemic preconditioning in the goat. Am J Physiol Heart Circ Physiol (2004) 0.80

Prognostic value of flow-mediated dilatation following myocardial infarction. Int J Cardiol (2008) 0.80

Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. Eur Heart J (2008) 0.79

Chronic systemic hypoxia promotes LNCaP prostate cancer growth in vivo. Prostate (2010) 0.79

Expression of carbohydrate-antigen sialyl-Lewis a on colon cancer cells promotes xenograft growth and angiogenesis in nude mice. Int J Biochem Cell Biol (2013) 0.79

Supplementation of creatine and ribose prevents apoptosis in ischemic cardiomyocytes. Cell Physiol Biochem (2011) 0.78

Impact of acellular hemoglobin-based oxygen carriers on brain apoptosis in rats. Transfusion (2014) 0.78

Low-flow ischemia and hypoxia stimulate apoptosis in perfused hearts independently of reperfusion. Cell Physiol Biochem (2002) 0.77

Effects of apelin on the cardiovascular system. Heart Fail Rev (2015) 0.77

Salmeterol improves fluid clearance from alveolar-capillary membrane in COPD patients: a pilot study. Pulm Pharmacol Ther (2012) 0.76

Autophagy and human parturition: evaluation of LC3 expression in placenta from spontaneous or medically induced onset of labor. Biomed Res Int (2013) 0.76

Modulation of the NO/cGMP pathway reduces the vasoconstriction induced by acellular and PEGylated haemoglobin. Biochim Biophys Acta (2008) 0.76

Comments on point:counterpoint: "the lactate paradox does/does not occur during exercise at high altitude". J Appl Physiol (1985) (2007) 0.75

Reveal LINQTM experience out of the electrophysiology lab. J Cardiovasc Med (Hagerstown) (2017) 0.75

Pulmonary Vascular Function and Aerobic Exercise Capacity at Moderate Altitude. Med Sci Sports Exerc (2017) 0.75

Pulmonary Vascular Function and Aerobic Exercise Capacityat Moderate Altitude. Med Sci Sports Exerc (2017) 0.75

Effects of broad band electromagnetic fields on HSP70 expression and ischemia-reperfusion in rat hearts. Life Sci (2004) 0.75

Supplementation of creatine and ribose prevents apoptosis and right ventricle hypertrophy in hypoxic hearts. Curr Pharm Des (2013) 0.75